PULMONX CORPORATION Lease, Cost
PULMONX CORPORATION (LUNG) reported Lease, Cost of $2.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-04
- PULMONX CORPORATION lease, cost for the quarter ending 2026-06-30 was $1.01M, a 10.23% increase year-over-year.
- PULMONX CORPORATION lease, cost for the quarter ending 2026-03-31 was $990.00K, a 0.10% increase year-over-year.
- PULMONX CORPORATION lease, cost for the quarter ending 2025-12-31 was $945.00K, a 2.38% decline year-over-year.
- PULMONX CORPORATION lease, cost for the quarter ending 2025-09-30 was $966.00K, a 1.47% increase year-over-year.
- PULMONX CORPORATION lease, cost for fiscal 2025 was $3.82M, a 1.19% decline from fiscal 2024.
- PULMONX CORPORATION lease, cost for fiscal 2024 was $3.87M, a 8.14% increase from fiscal 2023.
- PULMONX CORPORATION lease, cost for fiscal 2023 was $3.57M, a 1.33% increase from fiscal 2022.
- PULMONX CORPORATION lease, cost for fiscal 2022 was $3.53M, a 0.92% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.00M 10-Q · filed 2026-08-04 | $2.95M derived: sum of 3 quarters · filed 2026-08-04 | $3.91M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $990.00K 10-Q · filed 2026-05-04 | $1.94M derived: sum of 2 quarters · filed 2026-05-04 | $2.90M derived: sum of 3 quarters · filed 2026-05-04 | $3.82M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $945.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.91M derived: sum of 2 quarters · filed 2026-03-10 | $2.83M derived: sum of 3 quarters · filed 2026-08-04 | $3.82M 10-K · filed 2026-03-10 |
| 2025-09-30 | $966.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.89M derived: sum of 2 quarters · filed 2026-08-04 | $2.87M 10-Q · filed 2025-11-12 | $3.84M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $919.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.91M 10-Q · filed 2026-08-04 | $2.88M derived: sum of 3 quarters · filed 2026-08-04 | $3.83M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $989.00K 10-Q · filed 2026-05-04 | $1.96M derived: sum of 2 quarters · filed 2026-05-04 | $2.91M derived: sum of 3 quarters · filed 2026-05-04 | $3.83M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $968.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.92M derived: sum of 2 quarters · filed 2026-03-10 | $2.85M derived: sum of 3 quarters · filed 2026-03-10 | $3.87M 10-K · filed 2026-03-10 |
| 2024-09-30 | $952.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.88M derived: sum of 2 quarters · filed 2025-11-12 | $2.90M 10-Q · filed 2025-11-12 | $3.79M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $925.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $1.95M 10-Q · filed 2025-08-01 | $2.84M derived: sum of 3 quarters · filed 2025-08-01 | $3.74M derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | $1.02M 10-Q · filed 2025-05-02 | $1.92M derived: sum of 2 quarters · filed 2025-05-02 | $2.81M derived: sum of 3 quarters · filed 2025-05-02 | $3.71M derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $896.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.79M derived: sum of 2 quarters · filed 2025-02-25 | $2.69M derived: sum of 3 quarters · filed 2025-02-25 | $3.57M 10-K · filed 2025-02-25 |
| 2023-09-30 | $898.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $1.79M derived: sum of 2 quarters · filed 2024-11-01 | $2.68M 10-Q · filed 2024-11-01 | $3.56M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $897.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $1.78M 10-Q · filed 2024-08-02 | $2.66M derived: sum of 3 quarters · filed 2024-08-02 | $3.56M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $883.00K 10-Q · filed 2024-05-03 | $1.77M derived: sum of 2 quarters · filed 2024-05-03 | $2.66M derived: sum of 3 quarters · filed 2024-05-03 | $3.53M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $884.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.77M derived: sum of 2 quarters · filed 2024-02-27 | $2.65M derived: sum of 3 quarters · filed 2024-02-27 | $3.53M 10-K · filed 2024-02-27 |
| 2022-09-30 | $891.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $1.76M derived: sum of 2 quarters · filed 2023-11-03 | $2.64M 10-Q · filed 2023-11-03 | $3.52M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $872.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $1.75M 10-Q · filed 2023-08-04 | $2.63M derived: sum of 3 quarters · filed 2023-08-04 | $3.50M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $880.00K 10-Q · filed 2023-05-08 | $1.76M derived: sum of 2 quarters · filed 2023-05-08 | $2.62M derived: sum of 3 quarters · filed 2023-05-08 | $3.50M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $881.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.74M derived: sum of 2 quarters · filed 2023-03-01 | $2.62M derived: sum of 3 quarters · filed 2023-03-01 | $3.50M 10-K · filed 2023-03-01 |
| 2021-09-30 | $863.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.74M derived: sum of 2 quarters · filed 2022-11-08 | $2.61M 10-Q · filed 2022-11-08 | $3.48M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $873.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.75M 10-Q · filed 2022-08-08 | $2.62M derived: sum of 3 quarters · filed 2022-08-08 | $3.25M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $878.00K 10-Q · filed 2022-05-09 | $1.75M derived: sum of 2 quarters · filed 2022-05-09 | $2.38M derived: sum of 3 quarters · filed 2022-05-09 | $2.86M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $869.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.50M derived: sum of 2 quarters · filed 2022-03-01 | $1.98M derived: sum of 3 quarters · filed 2022-03-01 | $2.43M 10-K · filed 2022-03-01 |
| 2020-09-30 | $630.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.11M derived: sum of 2 quarters · filed 2021-11-09 | $1.56M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $485.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $928.00K 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | $443.00K 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | $1.28M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |